Ziyu Yu

435 total citations
9 papers, 291 citations indexed

About

Ziyu Yu is a scholar working on Molecular Biology, Ophthalmology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ziyu Yu has authored 9 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Ophthalmology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ziyu Yu's work include Retinal Development and Disorders (2 papers), Extracellular vesicles in disease (2 papers) and Retinal Diseases and Treatments (2 papers). Ziyu Yu is often cited by papers focused on Retinal Development and Disorders (2 papers), Extracellular vesicles in disease (2 papers) and Retinal Diseases and Treatments (2 papers). Ziyu Yu collaborates with scholars based in China and United States. Ziyu Yu's co-authors include Yehong Zhuo, Wenru Su, Nan Jiang, Yingting Zhu, Yingying Zhang, Ling Zhao, Zhidong Li, Song Guo Zheng, Yangyang Li and Yiqing Li and has published in prestigious journals such as Biomaterials, Frontiers in Pharmacology and Journal of Neuroinflammation.

In The Last Decade

Ziyu Yu

9 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziyu Yu China 6 199 57 55 48 41 9 291
Liping Xue China 13 203 1.0× 86 1.5× 99 1.8× 42 0.9× 33 0.8× 21 403
Nikolaos E. Efstathiou United States 8 158 0.8× 29 0.5× 50 0.9× 77 1.6× 20 0.5× 13 281
Yangyiran Xie United States 10 191 1.0× 113 2.0× 24 0.4× 49 1.0× 32 0.8× 20 380
Mengling You China 11 326 1.6× 153 2.7× 53 1.0× 121 2.5× 45 1.1× 22 497
Houda Tahiri Canada 12 259 1.3× 87 1.5× 68 1.2× 177 3.7× 45 1.1× 29 444
Peggy Bouzika United States 9 114 0.6× 43 0.8× 35 0.6× 111 2.3× 20 0.5× 12 301
Yvette Wooff Australia 10 253 1.3× 77 1.4× 96 1.7× 168 3.5× 81 2.0× 17 427
Patrick Robichaud United States 6 164 0.8× 29 0.5× 49 0.9× 12 0.3× 17 0.4× 8 359
Kathleen Jee United States 9 221 1.1× 110 1.9× 31 0.6× 171 3.6× 33 0.8× 15 440
Vanessa Delcroix United States 13 160 0.8× 37 0.6× 44 0.8× 24 0.5× 5 0.1× 17 323

Countries citing papers authored by Ziyu Yu

Since Specialization
Citations

This map shows the geographic impact of Ziyu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyu Yu more than expected).

Fields of papers citing papers by Ziyu Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziyu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyu Yu. The network helps show where Ziyu Yu may publish in the future.

Co-authorship network of co-authors of Ziyu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Ziyu Yu. A scholar is included among the top collaborators of Ziyu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziyu Yu. Ziyu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ding, Jin, Qian Zhang, Nina Zhou, et al.. (2024). Preclinical Evaluation and Pilot Clinical Study of 18F-Labeled Inhibitor Peptide for Noninvasive Positron Emission Tomography Mapping of Angiotensin Converting Enzyme 2. ACS Pharmacology & Translational Science. 7(6). 1758–1769. 2 indexed citations
2.
Wu, Jian, Caixia Lin, Chenlong Yang, et al.. (2023). Identification and validation of key biomarkers and potential therapeutic targets for primary open-angle glaucoma. Science China Life Sciences. 66(12). 2837–2850. 5 indexed citations
3.
Shi, Boyun, Wei Wang, Min Liang, et al.. (2023). Spermidine suppresses the activation of hepatic stellate cells to cure liver fibrosis through autophagy activator MAP1S. Liver International. 43(6). 1307–1319. 12 indexed citations
4.
Yu, Ziyu, Jian Wu, Yingting Zhu, et al.. (2023). Discovery of Clinical Manifestations in Spontaneous Glaucoma Suspect Nonhuman Primates. Ophthalmic Research. 66(1). 1406–1416. 2 indexed citations
5.
Li, Yangyang, Xiuxing Liu, Li Zhuang, et al.. (2022). Single-cell RNA sequencing reveals a landscape and targeted treatment of ferroptosis in retinal ischemia/reperfusion injury. Journal of Neuroinflammation. 19(1). 261–261. 38 indexed citations
6.
Yu, Ziyu, Nan Jiang, Zhidong Li, et al.. (2022). TNF-α stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3/miR-21a-5p axis. Biomaterials. 284. 121484–121484. 96 indexed citations
7.
Yu, Ziyu, Nan Jiang, Wenru Su, & Yehong Zhuo. (2021). Necroptosis: A Novel Pathway in Neuroinflammation. Frontiers in Pharmacology. 12. 701564–701564. 104 indexed citations
8.
Jiang, Nan, Zhidong Li, Zuohong Li, et al.. (2020). Laquinimod exerts anti-inflammatory and antiapoptotic effects in retinal ischemia/reperfusion injury. International Immunopharmacology. 88. 106989–106989. 28 indexed citations
9.
Liang, Xue, Ting Liu, Zhiming Zhang, & Ziyu Yu. (2020). Airway Inflammation Biomarker for Precise Management of Neutrophil-Predominant COPD. Methods in molecular biology. 2204. 181–191. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026